SandboxAQ brings its drug discovery models to Claude — no PhD in computing required

SandboxAQ integrates drug discovery AI models with Claude, prioritizing accessibility over raw model performance. This strategy signals a 2026 shift from building better AI to deploying it where domain experts lack coding skills. Expect enterprise adoption to depend less on model quality and more on reducing specialized expertise requirements, reshaping competitive dynamics in the AI economy.